| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/29/2004 | CA2513072A1 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512939A1 Modification of feeding behaviour and weight control by oxyntomodulin |
| 07/29/2004 | CA2512717A1 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | CA2512693A1 Novel proteins with altered immunogenicity |
| 07/29/2004 | CA2512681A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant |
| 07/29/2004 | CA2512680A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/29/2004 | CA2512672A1 Methods of treating lung diseases |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/29/2004 | CA2512337A1 Sirna mediated post-transcriptional gene silencing of genes involved in alopecia |
| 07/29/2004 | CA2512090A1 Cytokine inhibition of eosinophils |
| 07/29/2004 | CA2511858A1 Metastin derivative and use thereof |
| 07/29/2004 | CA2511800A1 Low efficacy gonadotropin agonists and antagonists |
| 07/29/2004 | CA2511659A1 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | CA2511564A1 Novel preadipocyte factor-1-like polypeptides |
| 07/29/2004 | CA2511530A1 Night-time oral insulin therapy |
| 07/29/2004 | CA2509422A1 Method for preparing recombinant heterocarpine |
| 07/29/2004 | CA2507008A1 Use of cc-chemokine mutants against liver diseases |
| 07/29/2004 | CA2506813A1 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |
| 07/28/2004 | EP1440980A2 Peptide analogs of human myelin basic protein |
| 07/28/2004 | EP1440979A1 Process for the preparation of hypoallergenic mosaic proteins |
| 07/28/2004 | EP1440977A1 Improved process for the preparation of diamidic derivatives of the tripeptid KPV |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440693A1 Medicament particularly for the treatment of diabetes mellitus |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440160A1 Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222 |
| 07/28/2004 | EP1440159A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/28/2004 | EP1440157A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2004 | EP1440156A2 Antigens and vectors for vaccination |
| 07/28/2004 | EP1440114A1 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 07/28/2004 | EP1440092A2 Photoactivatable composition and the use of same |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440090A2 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 07/28/2004 | EP1440089A2 Human angiomotin-like protein 1 |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1440084A2 Sperm factor sequences |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439862A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 07/28/2004 | EP1439854A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 07/28/2004 | EP1439853A2 Means for inhibition of lentiviruses |
| 07/28/2004 | EP1439852A1 Peptides and related compounds having thrombopoietic activity |
| 07/28/2004 | EP1439851A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394 |
| 07/28/2004 | EP1439850A1 Soluble proteins that inhibit cytokine signal transduction pathways |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1439848A1 L-methionine as a stabilizer for nesp/epo in hsa-free formulations |
| 07/28/2004 | EP1439846A2 Storage-stable human fibrinogen solutions |
| 07/28/2004 | EP1439844A1 Pharmaceutical preparation comprising a growth factor and/or a cytokine and an antiseptic biguanide |
| 07/28/2004 | EP1439840A1 Monobactam antibacterial compounds and methods of use thereof |
| 07/28/2004 | EP1439831A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 07/28/2004 | EP1439822A1 Metallothioneine-containing liposomes |
| 07/28/2004 | EP1439821A1 Pro-micelle pharmaceutical compositions |
| 07/28/2004 | EP1439820A2 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | EP1311660A4 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 07/28/2004 | EP1284994B1 Use of a high-molecular-weight extracellular haemoglobin as blood substitute |
| 07/28/2004 | EP1284749B1 Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 07/28/2004 | EP1278536B1 Depletion method of blood plasma ascorbate |
| 07/28/2004 | EP1238095A4 Compositions and methods for caspase-induced apoptosis |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1223990B1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 07/28/2004 | EP1183042B1 Methods for treating diabetes |
| 07/28/2004 | EP1047781B1 Il-18 receptors |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP0941311B1 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 07/28/2004 | EP0935607B1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 07/28/2004 | EP0920509B1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0910629B1 Process for producing a basic antidote substance for natural and synthetic thrombin inhibitors |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | EP0752884B1 Method of treating auto-immune diseases using type one interferons |
| 07/28/2004 | EP0719332B1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/28/2004 | EP0696201B1 Supplemented tissue sealants, methods of their production and use |
| 07/28/2004 | EP0584214B1 Gene manipulation and expression using genomic elements |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516738A Acetylation of GP41 framgnets |
| 07/28/2004 | CN1516606A Dry powder inhalation system for transpulmonary administration |
| 07/28/2004 | CN1516599A Method for joint treatment of chronic hepatitis C infection using ribavirin-polyvinyl glycol interferon alpha |
| 07/28/2004 | CN1516598A Antimicrobial peptides |
| 07/28/2004 | CN1516597A Diagnostic indicator of thymic function |
| 07/28/2004 | CN1516596A Method of modulating activity of calcium channels in cardiac cells and reagents therefor |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1516591A Preparation of therapeutic composition |
| 07/28/2004 | CN1516582A 抗病毒化合物 Antiviral compounds |
| 07/28/2004 | CN1516550A Flexible container system for storage of stabilized hemoglobin solutions |
| 07/28/2004 | CN1515680A Application of ion channel inhibitor for curing arhythmia |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1515588A Biological function of human testis specific gene HSD-3,8 coded protein |